Aurora Cannabis Inc. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Aurora Cannabis Inc. on November 9, 2020, covering the interim period ended September 30, 2020. The filing serves to distribute the company's Condensed Consolidated Interim Financial Statements and Management's Discussion and Analysis (MD&A) for the three months ended September 30, 2020, and the comparable period in 2019.
Key Financial Metrics
The filing text provided is a cover sheet and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached exhibits (Exhibit 99.1 and 99.2) referenced in the document but are not present in the source text provided for analysis.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. The document indicates that the financial statements and MD&A for the three months ended September 30, 2020, and 2019, are submitted as exhibits, where such comparisons would be detailed.
Guidance, Outlook, and Risks
Specific guidance, outlook, management commentary, risks, contingencies, or unusual items are not detailed in the cover sheet text. This information is located in the Management's Discussion and Analysis (Exhibit 99.2) attached to the filing.
Investor Verification Checklist
- Review Exhibit 99.1 for the Condensed Consolidated Interim Financial Statements to verify revenue, net loss, and cash position for the quarter ended September 30, 2020.
- Examine Exhibit 99.2 (MD&A) for management's explanation of financial performance, liquidity risks, and operational updates.
- Compare the September 30, 2020, results against the September 30, 2019, figures provided in the exhibits to assess year-over-year trends.
- Verify the certifications signed by the Chief Executive Officer and Chief Financial Officer (Exhibits 99.3 and 99.4) regarding the accuracy of the financial data.